Media are Invited to Register Now For a Live, CAP-Exclusive Event … MEDIA ALERT … Download image CAP logo. (PRNewsFoto/College of American Pathologists) WASHINGTON, June 19, 2013 /PRNewswire-USNewswire/ -- Genomic medicine has the potential to be a cornerstone of medical testing, treatment, and clinical integration. Without doubt, the Supreme Court's unanimous decision invalidating Myriad's patents on BRCA1 and BRCA2 is already changing the testing landscape for those genes. What other changes can we expect? How will the decision impact medical testing? What did it take to win the case? (Logo: http://photos.prnewswire.com/prnh/20120314/DC69899LOGO-a ) As a co-plaintiff in this landmark...
↧